Luxbright AB (publ) (LXB.ST) Stock Analysis & Winston Score
Luxbright AB is a Swedish medical technology company that develops advanced X-ray tubes used in medical imaging equipment. Its core product is a cold cathode X-ray tube based on carbon nanotube technology, which is designed to produce sharper images while using less energy than traditional X-ray tubes. The company targets medical device manufacturers and imaging system makers as its main customers. Luxbright makes money by selling its X-ray tube technology and components, though it is still in an early commercial stage and has not yet reached profitability. The company operates primarily out of Sweden and is very small, with a market cap near zero and deeply negative margins, meaning it spends far more than it earns. Its main competitive angle is its proprietary carbon nanotube emitter technology, which could differentiate it in the medical imaging market — but the biggest risk is that it may struggle to secure enough customer contracts and funding to survive long enough to scale its business.
Winston Score: 33/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Weak (1/30)
- Growth: Strong (15/20)
- Cash Flow: Weak (0/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
